Qiu Huazhang, Wu Namei, Zheng Yanjie, Chen Min, Weng Shaohuang, Chen Yuanzhong, Lin Xinhua
Department of Pharmaceutical Analysis, Faculty of Pharmacy, Fujian Medical University, Fuzhou, People's Republic of China.
Department of Orthopedic Surgery, Affiliated Union Hospital of Fujian Medical University, Fuzhou, People's Republic of China.
Int J Nanomedicine. 2014 Dec 22;10:147-56. doi: 10.2147/IJN.S68638. eCollection 2015.
A robust and versatile signal-on fluorescence sensing strategy was developed to provide label-free detection of various target analytes. The strategy used SYBR Green I dye and graphene oxide as signal reporter and signal-to-background ratio enhancer, respectively. Multidrug resistance protein 1 (MDR1) gene and mercury ion (Hg(2+)) were selected as target analytes to investigate the generality of the method. The linear relationship and specificity of the detections showed that the sensitive and selective analyses of target analytes could be achieved by the proposed strategy with low detection limits of 0.5 and 2.2 nM for MDR1 gene and Hg(2+), respectively. Moreover, the strategy was used to detect real samples. Analytical results of MDR1 gene in the serum indicated that the developed method is a promising alternative approach for real applications in complex systems. Furthermore, the recovery of the proposed method for Hg(2+) detection was acceptable. Thus, the developed label-free signal-on fluorescence sensing strategy exhibited excellent universality, sensitivity, and handling convenience.
开发了一种强大且通用的信号开启荧光传感策略,用于对各种目标分析物进行无标记检测。该策略分别使用SYBR Green I染料和氧化石墨烯作为信号报告分子和信号背景比增强剂。选择多药耐药蛋白1(MDR1)基因和汞离子(Hg(2+))作为目标分析物来研究该方法的通用性。检测的线性关系和特异性表明,所提出的策略能够实现对目标分析物的灵敏且选择性分析,对MDR1基因和Hg(2+)的检测限分别低至0.5和2.2 nM。此外,该策略还用于检测实际样品。血清中MDR1基因的分析结果表明,所开发的方法是复杂系统实际应用中一种有前景的替代方法。此外,所提出的Hg(2+)检测方法的回收率是可接受的。因此,所开发的无标记信号开启荧光传感策略具有出色的通用性、灵敏度和操作便利性。